Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus for PAD Below the Knee (TANGO-3)
NCT04433572Phase 3Recruiting
- Sponsor
- Mercator MedSystems
- Start
- Jul 2025
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of temsirolimus in peripheral artery disease (PAD), critical limb ischemia (CLI), sponsored by Mercator MedSystems. Started Jul 2025; status: recruiting.
02
Drugs
temsirolimus
03
Conditions
peripheral artery disease (PAD)critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT04433572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04433572.